SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-047426
Filing Date
2023-04-20
Accepted
2023-04-20 07:30:30
Documents
14
Period of Report
2023-04-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2313283d1_8k.htm   iXBRL 8-K 30322
2 EXHIIT 99.1 tm2313283d1_ex99-1.htm EX-99.1 15337
6 GRAPHIC tm2313283d1_ex99-1img001.jpg GRAPHIC 60737
  Complete submission text file 0001104659-23-047426.txt   310388

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ctso-20230417.xsd EX-101.SCH 3045
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctso-20230417_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctso-20230417_pre.xml EX-101.PRE 22603
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2313283d1_8k_htm.xml XML 3483
Mailing Address 305 COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address 305 COLLEGE ROAD EAST PRINCETON NJ 08540 973-329-8885
Cytosorbents Corp (Filer) CIK: 0001175151 (see all company filings)

IRS No.: 980373793 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36792 | Film No.: 23831409
SIC: 3841 Surgical & Medical Instruments & Apparatus